These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6429698)

  • 1. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
    Hyttel J; Overø KF; Arnt J
    Psychopharmacology (Berl); 1984; 83(1):20-7. PubMed ID: 6429698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
    Arnt J; Hyttel J; Larsen JJ
    Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes.
    Bonanno G; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):219-25. PubMed ID: 3473290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.
    Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J
    Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Hashimoto K; Goromaru T
    Neuropharmacology; 1991 Feb; 30(2):113-7. PubMed ID: 2030818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study.
    Arranz B; Marcusson J
    J Neural Transm Gen Sect; 1994; 97(1):27-40. PubMed ID: 7888147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.
    Hyttel J
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):277-95. PubMed ID: 6128769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus.
    Blier P; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1990 Jul; 254(1):236-44. PubMed ID: 2164092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
    Ellison DW; Campbell IC
    J Neurochem; 1986 Jan; 46(1):218-23. PubMed ID: 2415679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.
    Chaput Y; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):342-8. PubMed ID: 3022157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.